HBM Healthcare Investments AG (HBMN) CHF41.80

Sell:197.60 CHFBuy:199.20 CHFNo change

Prices delayed by at least 15 minutes
Sell:197.60 CHF
Buy:199.20 CHF
Change:No change
Prices delayed by at least 15 minutes
Sell:197.60 CHF
Buy:199.20 CHF
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Key people

Andreas Wicki
Chief Executive Officer
Erwin Troxler
Chief Financial Officer
Benedikt Suter
Secretary
Hans Peter Hasler
Chairman of the Board
Mario Germano Giuliani
Member of the Board
Elaine V. Jones
Member of the Board
Rudolf Lanz
Member of the Board
Stella X. Xu
Member of the Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    Switzerland
  • Sector
    Financial
  • Industry
    Misc. Financial Services
  • ISIN
    CH0012627250
  • Market cap
    CHF 1.39bn
  • Employees
    -
  • Shares in issue
    6.96m
  • Exchange
    SIX Swiss Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.